Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • EGFR
    (2)
  • Others
    (1)
Filter
Search Result
Results for "

abt 806

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    3
    TargetMol | Inhibitors_Agonists
  • Inhibitory Antibodies
    3
    TargetMol | Inhibitory_Antibodies
Depatuxizumab
ABT-806, ABT806
T783261471999-69-5
Depatuxizumab is a humanised monoclonal antibody targeting EGFR with blood-brain barrier (BBB) permeability, capable of inhibiting the growth of xenograft tumours expressing mutant EGFR vIII and wild-type EGFR. It can be conjugated with the ADC molecule Depatuxizumab mafodotin for the study of glioblastoma (GBM) and head and neck squamous cell carcinoma (SCCHN).
  • $415
In Stock
Size
QTY
Losatuxizumab
ABT-806, ABT806
T770731801544-27-3
Losatuxizumab (ABT-806) is an anti-EGFR monoclonal antibody that is a naked antibody to the ADC compound Losatuxizumab vedotin, with potential anti-tumor activity for the study of advanced malignant solid tumors.
  • $197
In Stock
Size
QTY
Serclutamab talirine
ABBV-321
T9901A-0262140174-56-5
Serclutamab talirine (ABBV-321), an EGFR-targeted antibody-drug conjugate (ADC), comprises the AM-1-ABT-806 antibody, which targets activated EGFR, and a pyrrolobenzodiazepine (PBD) dimer. This compound displays potent antitumor activity [1].
  • Inquiry Price
Size
QTY